Werewolf Therapeutics

HOWL

Market cap $17.6M

HOWL Hedge Fund Activity: Q1 2026 in Review

48 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Werewolf Therapeutics (HOWL) for Q1 2026, worth a combined $11.7M — up 25% from $9.34M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of HOWL and 10 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was Squadron Capital Management, opening a new position worth an estimated $386K. The largest seller was Bank of America, cutting an estimated $324K.

• 48 institutional investors held Werewolf Therapeutics (HOWL) as of Q1 2026, down from 51 in Q4 2025.
• Funds reported $11.7M of Werewolf Therapeutics stock for Q1 2026, up 25% quarter-over-quarter.
• 10 funds opened new Werewolf Therapeutics positions in Q1 2026 and 12 closed out, a net change of -2 holders.
• The largest Werewolf Therapeutics buyer in Q1 2026 was Squadron Capital Management, an estimated $386K added.
• The largest Werewolf Therapeutics seller in Q1 2026 was Bank of America, an estimated $324K sold.

Based on aggregated 13F filings for Q1 2026.